Surrozen, Inc. (SRZN)
NASDAQ: SRZN · Real-Time Price · USD
8.00
-0.35 (-4.19%)
May 12, 2025, 4:00 PM - Market closed
Surrozen Employees
As of December 31, 2024, Surrozen had 41 total employees, including 40 full-time and 1 part-time employees. The number of employees decreased by 1 or -2.38% compared to the previous year.
Employees
41
Change (1Y)
-1
Growth (1Y)
-2.38%
Revenue / Employee
$283,854
Profits / Employee
-$1,992,780
Market Cap
67.96M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 41 | -1 | -2.38% |
| Dec 31, 2023 | 42 | -32 | -43.24% |
| Dec 31, 2022 | 74 | -9 | -10.84% |
| Dec 31, 2021 | 83 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
SRZN News
- 3 days ago - Surrozen Reports First Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 6 weeks ago - Surrozen Provides Fourth Quarter and Full Year 2024 Financial Results and Business Updates - GlobeNewsWire
- 7 weeks ago - Surrozen Announces an Oversubscribed $175 Million Private Placement of Securities to Focus on Selective Wnt Mimetic Therapeutics to Treat Serious Eye Diseases - GlobeNewsWire
- 6 months ago - Surrozen to Present at Upcoming Healthcare Investor Conferences - GlobeNewsWire
- 6 months ago - Surrozen Provides Third Quarter 2024 Financial Results and Business Update - GlobeNewsWire
- 6 months ago - Surrozen and TCGFB, Inc. Announce Strategic Research Collaboration to Develop TGF-β Antibodies for Idiopathic Pulmonary Fibrosis - GlobeNewsWire
- 8 months ago - Surrozen Earns $10 Million Milestone Payment in Retinal Diseases Collaboration - GlobeNewsWire
- 9 months ago - Surrozen Provides Second Quarter 2024 Financial Results and Business Update - GlobeNewsWire